InvestorsHub Logo
Followers 7
Posts 2184
Boards Moderated 0
Alias Born 12/20/2017

Re: namah sivaya post# 5276

Thursday, 03/14/2019 11:24:28 AM

Thursday, March 14, 2019 11:24:28 AM

Post# of 16697
Positive Breathalyzer developments...would be a great sign.

IMHO the medical breathalyzer is our best shot for superstardom here. That is technology that can change the industry. Money spent developing this technology would put ALGERNON on a map where others don't exist. This could draw far more big Pharma money.....and they don't have that pesky 70% failure rate....that drug repurposing does.

The medical diseases ALGERNON is researching compounds for.....are serious and need better drugs than currently available. IF ALGERNON's mystery compounds could somehow skip Phase I and begin Phase II trials...we face a 70% failure rate...trying to get through FDA approval

We have four mystery compounds that have risen to the top of our search for repurposing drugs in needed fields. At $30 million each to get through trials.....we need $120 million dollars.

If we have great results after our mouse trials...where will the money come from?

Pharma money could turn the medical breathalyzer into a goldmine....with the list of diseases it could detect able to be added as development went on.

GLTA